Harmine
| Clinical data | |
|---|---|
| Other names | Banisterine; Leucoharmine; Telepathine; Yageine; 7-Methoxy-1-methyl-β-carboline |
| Routes of administration | Oral, sublingual, subcutaneous injection, intramuscular injection, intravenous injection |
| Drug class | Hallucinogen; Monoamine oxidase inhibitor (MAOI); Reversible inhibitor of monoamine oxidase A (RIMA) |
| Identifiers | |
IUPAC name
| |
| CAS Number | |
| PubChem CID | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.006.485 |
| Chemical and physical data | |
| Formula | C13H12N2O |
| Molar mass | 212.252 g·mol−1 |
| 3D model (JSmol) | |
| Density | 1.326 g/cm3 g/cm3 |
| Melting point | 321 °C (610 °F) (·HCl); 262 °C (·HCl·2H2O)[1] |
| Solubility in water | insoluble[2] mg/mL (20 °C) |
SMILES
| |
InChI
| |
| (verify) | |
Harmine, also known as banisterine or telepathine among other synonyms,[a] is a β-carboline and a harmala alkaloid.[5] It occurs in a number of different plants, most notably Peganum harmala and Banisteriopsis caapi.[4] Harmine reversibly inhibits monoamine oxidase A (MAO-A), an enzyme which breaks down monoamines, making it a reversible inhibitor of monoamine oxidase A (RIMA). Harmine does not inhibit MAO-B.[6]
The biosynthesis of harmine likely begins with L-tryptophan, which is decarboxylated to tryptamine—an intermediate also used in serotonin synthesis—before undergoing a series of reactions to form harmine, with feeding experiments supporting tryptamine’s role as an intermediate rather than a primary precursor. It is essential for enabling the oral activity of DMT in ayahuasca and is also used as a fluorescent pH indicator and in PET imaging to study MAO-A-related brain disorders.
Pharmaceutical-grade harmine hydrochloride is safe and well-tolerated at oral doses below 2.7 mg/kg in healthy adults, with higher doses causing mild to moderate gastrointestinal and neurological side effects and limited psychoactive effects. It is found in various plants—including tobacco, Passiflora species, lemon balm, and several Banisteriopsis species—as well as in some butterflies of the Nymphalidae family. Harmine was first isolated and named by in 1848 from Peganum harmala seeds, later identified in Banisteriopsis caapi under various names, with its structure determined in 1927. Recent patents focus on creating harmine derivatives with reduced toxicity.
- ^ The Merck Index (1996). 12th edition
- ^ "Harmine - CAS 442-51-3". scbio.de. Santa Cruz Biotechnology, Inc. Retrieved 27 October 2015.
- ^ Allen JR, Holmstedt BR (1980). "The simple β-carboline alkaloids". Phytochemistry. 19 (8): 1573–1582. Bibcode:1980PChem..19.1573A. doi:10.1016/S0031-9422(00)83773-5.
- ^ a b Djamshidian A, Bernschneider-Reif S, Poewe W, Lees AJ (2015). "Banisteriopsis caapi, a Forgotten Potential Therapy for Parkinson's Disease?". Movement Disorders Clinical Practice. 3 (1): 19–26. doi:10.1002/mdc3.12242. PMC 6353393. PMID 30713897.
- ^ Brimblecombe RW, Pinder RM (1975). "Indolealkylamines and Related Compounds". Hallucinogenic Agents. Bristol: Wright-Scientechnica. pp. 98–144. ISBN 978-0-85608-011-1. OCLC 2176880. OL 4850660M.
- ^ Frecska E, Bokor P, Winkelman M (2016). "The Therapeutic Potentials of Ayahuasca: Possible Effects against Various Diseases of Civilization". Frontiers in Pharmacology. 7: 35. doi:10.3389/fphar.2016.00035. PMC 4773875. PMID 26973523.
Cite error: There are <ref group=lower-alpha> tags or {{efn}} templates on this page, but the references will not show without a {{reflist|group=lower-alpha}} template or {{notelist}} template (see the help page).